why choose us

First received: September 21, 2023

Clinical Trial: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Malignant Peritoneal Mesothelioma

Study Type: INTERVENTIONAL


Official Title: ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreduc

Brief Summary: The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal mesothelioma.Outcomes will be compared by observing intraperitoneal versus intravenous treatments to analyze if one is better than the other.

Read more